Skip to main content

Enrollment in the Health Benefits for Immigrant Adults (HBIA) program will be temporarily paused effective July 1, 2023.

Enrollment in the Health Benefits for Immigrant Seniors (HBIS) program will be temporarily paused effective Nov. 6, 2023.

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: May 18, 2011

Drug Name Review Type Class Manufacturer
Dulera New Drug Appeal Beta Adrenergic/Glucocorticoid Merck
Seroquel PDL Appeal Atypical Antipsychotic Astra Zeneca
Seroquel XR PDL Appeal Atypical Antipsychotic Astra Zeneca